title: Immunoglobulin i.v. high dose (IVIgHD): new therapy as a rescue treatment of grafted kidneys.
authors.affiliation: Insitituto de Nefralogia, Buenos Aires, Argentina.
authors.forename: D
authors.initials: D
authors.lastname: Casadei
authors.forename: M
authors.initials: M
authors.lastname: Rial
authors.forename: E
authors.initials: E
authors.lastname: Raimondi
authors.forename: J
authors.initials: J
authors.lastname: Goldberg
authors.forename: J
authors.initials: J
authors.lastname: Argento
authors.forename: E
authors.initials: E
authors.lastname: Haas
mesh_terms: D001379:Azathioprine / Q000627:therapeutic use; D001707:Biopsy, Needle; D016572:Cyclosporine / Q000627:therapeutic use; D006084:Graft Rejection / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D006684:HLA-DR Antigens / Q000032:analysis / Q000096:biosynthesis; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology* / Q000473:pathology; D011241:Prednisone / Q000627:therapeutic use
chemical_list: D006684:HLA-DR Antigens; D016756:Immunoglobulins, Intravenous; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D001379:Azathioprine; D011241:Prednisone